In the perioperative management of patients taking SGLT2 inhibitors, the optimal approach for preventing EDKA is to withhold the medication in any setting where predisposing factors for ketoacidosis are present (e.g
[1] [5] Currently available GLP-1 medications in the United States include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide (Byetta, Bydureon), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GLP-1/GIP receptor agonist
After symptoms resolve, a slower re-escalation can be attempted, perhaps increasing by smaller increments than the standard protocol specifies
As your primary care provider, we also look at: Your overall health For example, we note if you have other medical conditions that could affect your ability to lose weight, such as hypothyroidism